Search Reports

Showing search results for "All"

Below you can search for shortage and discontinuation reports that have been submitted for drug products by a company.

For more information on how to search reports, see “How to Search” section in the Website overview for public users, found in the About & Resources page.

The “Export results” button on the search reports page will create individual CSV files for shortage reports and discontinuation reports containing data from the search results. Please note that the two CSV files will be downloaded in a single .zip file. Users would then need to open the .zip file to access the CSV files.

To search by product, please refer to the Search Product page.

A public access API (application program interface) is also available to access shortage and discontinuation report data in an alternative format. Public API Access.

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Search by keyword, including DIN, company name, and drug name
Date range:
Start date
To
End date
Type
Select from the options in the checkboxes/dropdown menu below to filter your results by report type.
Tier 3 status
Filter by reports that have been designated Tier 3 by Health Canada. Learn more
Status:
Select from the options in the checkboxes/dropdown menu below to filter your results by status type

List of shortage and discontinuation reports search results
Status Brand name Company Name Strength(s) Date Updated View Report
Resolved GLYCOPYRROLATE INJECTION MULTIDOSE OMEGA LABORATORIES LIMITED 0.2MG 2020-01-08 98404
Resolved GLYCOPYRROLATE INJECTION MULTIDOSE OMEGA LABORATORIES LIMITED 0.2MG 2020-06-16 109803
Resolved GLYCOPYRROLATE INJECTION USP SANDOZ CANADA INCORPORATED 0.2MG 2023-12-05 210061
Resolved GLYCOPYRROLATE INJECTION USP STERIMAX INC 0.2MG 2023-01-19 169242
Anticipated shortage GLYCOPYRROLATE INJECTION USP STERIMAX INC 4MG 2026-03-26 281526
Resolved GLYCOPYRROLATE INJECTION USP SANDOZ CANADA INCORPORATED 0.2MG 2023-04-05 186160
Resolved GLYCOPYRROLATE INJECTION USP STERIMAX INC 0.2MG 2023-09-30 200632
Resolved GLYCOPYRROLATE INJECTION USP SANDOZ CANADA INCORPORATED 0.2MG 2023-10-11 204118
Resolved GLYCOPYRROLATE INJECTION USP STERIMAX INC 0.4MG 2026-03-12 271235
Actual shortage GLYCOPYRROLATE INJECTION USP JAMP PHARMA CORPORATION 0.2MG 2026-03-20 280946
Resolved GLYCOPYRROLATE INJECTION USP STERIMAX INC 4MG 2025-09-18 234808
Resolved GLYCOPYRROLATE INJECTION USP SANDOZ CANADA INCORPORATED 0.2MG 2022-11-29 167366
Resolved GLYCOPYRROLATE INJECTION USP STERIMAX INC 0.4MG 2023-04-17 181847
Resolved GLYCOPYRROLATE INJECTION USP SANDOZ CANADA INCORPORATED 0.2MG 2022-03-15 154523
Resolved GLYCOPYRROLATE INJECTION USP STERIMAX INC 0.4MG 2025-09-18 245519
Resolved GLYCOPYRROLATE INJECTION USP STERIMAX INC 0.2MG 2026-03-12 244055
Resolved GLYCOPYRROLATE INJECTION USP STERIMAX INC 4MG 2023-02-02 177192
Resolved GLYCOPYRROLATE INJECTION USP SANDOZ CANADA INCORPORATED 0.2MG 2026-03-31 281145
Resolved GLYCOPYRROLATE INJECTION USP SANDOZ CANADA INCORPORATED 0.2MG 2022-11-29 167369
Discontinued GLYXAMBI BOEHRINGER INGELHEIM (CANADA) LTD LTEE 5MG 10MG 2021-06-12 139870

Showing 10641 to 10660 of 28522